-
Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Lowered to $55.00 at Robert W. Baird
Source: Buzz FX / 07 Nov 2024 14:06:18 America/New_York
Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Lowered to $55.00 at Robert W. Baird Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Apellis Pharmaceuticals ( NASDAQ:APLS - Get Free Report ) had its price objective
Read more...